clinical trial · NCT05718700
Study of Bulevirtide in Participants With Chronic Hepatitis D Infection
Gilead Sciences·—·active not recruiting·n = 170
Chronic Hepatitis D InfectionBulevirtide
brief summary
The main goal of this study is to collect post marketing data from patients with chronic hepatitis D virus (HDV) infection who are treated with bulevirtide to describe the long-term effects of bulevirtide treatment and evaluate the safety of participants treated with bulevirtide.
started
Feb 7, 2023
primary completion
Jul 1, 2028
completion
Jul 1, 2028
last updated
Nov 17, 2025
detailed description
The study design time perspective is retrospective and prospective for participants who previously participated in MYR-Reg-02 and are currently receiving BLV and prospective for participants who are scheduled to receive BLV.
official title
A Registry Study of Treatment With Bulevirtide in Participants With Chronic Hepatitis D Infection
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol